| Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in China (NCT05451082) | Lai Wei | 2022-07-01 |
| Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus (NCT06360484) | National Center for Gastroentestinal and Liver Disease | 2022-06-01 |
| Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) (NCT04863703) | Hannover Medical School | 2021-05-07 |
| A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection (NCT04847440) | Antios Therapeutics, Inc | 2021-03-30 |
| Epidemiology of Hepatitis B, C and Delta in Reunion Island (NCT03362866) | Centre Hospitalier Universitaire de la Réunion | 2019-01-01 |
| Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon (NCT03600714) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-08-01 |
| Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi) (NCT05002907) | Centre Hospitalier de Cayenne | 2018-01-01 |
| Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) (NCT02577029) | Arrowhead Pharmaceuticals | 2015-12-01 |
| Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir (NCT02511431) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-07-29 |
| Mother-to-child Hepatitis D Transmission (NCT02044055) | Hopital Lariboisière | 2014-10-01 |
| The Hepatitis Delta International Network (NCT02375906) | HepNet Study House, German Liverfoundation | 2013-11-01 |
| Lonafarnib for Chronic Hepatitis D (NCT01495585) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2011-12-01 |
| Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV) (NCT01316185) | Eiger BioPharmaceuticals | 2011-01-01 |
| HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis (NCT00932971) | HepNet Study House, German Liverfoundation | 2009-06-01 |
| Pegylated Interferon to Treat Chronic Hepatitis D (NCT00023322) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2001-08-01 |
| Evaluation of Patients With Liver Disease (NCT00001971) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1992-05-27 |